Why the study?
Does glibenclamide prevent hypoglycemia-induced fatal cardiac arrhythmias and mortality in a rat model of severe hypoglycemia?
Does glibenclamide prevent hypoglycemia-induced fatal cardiac arrhythmias and mortality in a rat model of severe hypoglycemia?
Glibenclamide demonstrates a paradoxical protective role against severe hypoglycemia-induced fatal cardiac arrhythmias and mortality in a rat model.
Answers are grounded in this paper and cite their sources.
May protect against fatal arrhythmias during severe hypoglycemia; leaves open whether KATP modulation alters sudden death risk in diabetes.
Sulfonylureas increase the incidence of severe hypoglycemia in people with type 2 diabetes and might increase the risk of sudden cardiac death. Sulfonylureas stimulate insulin secretion by closing pancreatic ATP-sensitive potassium ion (KATP) channels. To investigate the role of KATP channel modulators on cardiac arrhythmias and mortality in the setting of severe hypoglycemia, adult Sprague-Dawley rats underwent hyperinsulinemic (0.2 U/kg/min) severe hypoglycemic (10 to 15 mg/dL) clamps with continuous electrocardiography. The rats were randomized for treatment with intravenous vehicle (VEH), the sulfonylurea glibenclamide (GLIB; KATP channel blocker; 5 mg/kg/h), or diazoxide (DIAZ; KATP channel opener; 5 mg/kg/h). The results demonstrated that GLIB completely prevented first-degree heart block compared with VEH (0.18 ± 0.09/min) and DIAZ (0.2 ± 0.05/min). Second-degree heart block was significantly reduced with GLIB (0.12 ± 0.1/min) compared with VEH (0.6 ± 0.2/min) and DIAZ (6.9 ± 3/min). The incidence of third-degree heart block was completely prevented by GLIB compared with VEH (67%) and DIAZ (87.5%). Hypoglycemia-induced mortality was completely prevented by GLIB compared with VEH (60%) and DIAZ (82%). In conclusion, although GLIB increases the risk of hypoglycemia by increasing insulin secretion, these results have demonstrated a paradoxical protective role of GLIB against severe hypoglycemia-induced fatal cardiac arrhythmias.
No takes yet. Share an insight, caveat, or question.
Reno et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: